Nuvation Bio Inc. Class A Common Stock (NUVB)
Stock · NYSE · Health Care
$4.43as of 10/16/2026
Price chart
Active signals
NUVB Signal Track Record
How signals performed across all stocks →What NUVB's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 41 | +1.9% | 54% | October 2, 2026 |
| Bollinger Band Breakout | 29 | -2.2% | 41% | August 18, 2026 |
| Bollinger Band Breakdown | 17 | -1.0% | 47% | October 5, 2026 |
| 200-Day Moving Average TouchActive now | 10 | +1.9% | 60% | September 14, 2026 |
| Any 20-session window (baseline) | +1.8% | 53% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About NUVB
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on developing product candidates for cancer treatment. The company's lead product candidate is IBTROZI (taletrectinib), a ROS1 inhibitor for the treatment of patients with ROS1+ non-small cell lung cancer. It is also developing Safusidenib, an inhibitor of mutant isocitrate dehydrogenase 1 in phase 3 clinical trials for the maintenance treatment o…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 305
- Website
- www.nuvationbio.com/
Fundamentals
- 1-day range
- $4.67$4.86
- Market cap
- $2.13B
- P/E (trailing)
- —
- P/E (forward)
- -316.67
- EPS (trailing)
- $-0.44
- Dividend yield
- —
- Beta
- 1.71
- Avg. volume
- 5.59M
How Nuvation Bio Inc. Class A Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 2, 2026 · via SEC EDGAR / Finnhub
Forecasts
11 analyst ratings
Nuvation Bio Inc. Class A Common Stock Competitors
Chosen by industry and closest market cap.
- NUVBNuvation Bio Inc. Class A Common Stock$4.45▼ 6.32%Market cap $2.13BP/E —$3.36$9.75
- GHRSGH Research PLC Ordinary Shares$18.15▼ 3.51%Market cap $2.10BP/E —$12.04$31.44
- AUPHAurinia Pharmaceuticals Inc Ordinary Shares$16.51▼ 1.31%Market cap $2.10BP/E 7.11$11.21$19.25
- BHVNBiohaven Ltd. Common Shares$10.78▼ 5.69%Market cap $2.17BP/E —$7.48$18.57
- SLSSELLAS Life Sciences Group Inc. Common Stock$9.98▼ 11.99%Market cap $2.18BP/E —$1.39$15.88
- HCMHUTCHMED (China) Limited American Depositary Shares$14.05▲ 0.79%Market cap $2.06BP/E 133.15$15.57$26
- STOKStoke Therapeutics Inc. Common Stock$24.17▼ 1.79%Market cap $2.06BP/E —$20.32$40.22
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| NUVB Nuvation Bio Inc. Class A Common Stock | $2.13B | — | $4.45 | ▼ 6.32% | $3.36$9.75 |
| GHRS GH Research PLC Ordinary Shares | $2.10B | — | $18.15 | ▼ 3.51% | $12.04$31.44 |
| AUPH Aurinia Pharmaceuticals Inc Ordinary Shares | $2.10B | 7.11 | $16.51 | ▼ 1.31% | $11.21$19.25 |
| BHVN Biohaven Ltd. Common Shares | $2.17B | — | $10.78 | ▼ 5.69% | $7.48$18.57 |
| SLS SELLAS Life Sciences Group Inc. Common Stock | $2.18B | — | $9.98 | ▼ 11.99% | $1.39$15.88 |
| HCM HUTCHMED (China) Limited American Depositary Shares | $2.06B | 133.15 | $14.05 | ▲ 0.79% | $15.57$26 |
| STOK Stoke Therapeutics Inc. Common Stock | $2.06B | — | $24.17 | ▼ 1.79% | $20.32$40.22 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Ventia Services Group And 2 Top Penny StocksYahoo · 10/10/2026
- Top Penny Stocks To Own In October 2026Yahoo · 10/3/2026
- Citigroup Initiates Coverage of Nuvation Bio with BuyFintel · 9/30/2026
- This Ciena Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesdaybenzinga · 9/30/2026
- This Ciena Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For WednesdayBenzinga · 9/30/2026
- Citigroup Initiates Coverage On Nuvation Bio with Buy Rating, Announces Price Target of $12Benzinga · 9/30/2026
- 5 Undervalued Oncology Stocks Wall Street Is OverlookingSeekingAlpha · 9/18/2026
- Sector Update: Healthcare Stocks Rise Thursday AfternoonYahoo · 9/17/2026
- Why Is Nuvation Bio Stock Gaining Thursday?Benzinga · 9/17/2026
Insider Activity
Insider Actions →- Gary Hattersley · August 19, 2026 · Option Exercise100.0K @ $1.87
- Gary Hattersley · August 19, 2026 · Sale100.0K @ $7.09
- Philippe Sauvage · July 15, 2026 · Option Exercise1 @ $1.97
- Philippe Sauvage · July 15, 2026 · Option Exercise40.0K @ $2.17
- Philippe Sauvage · June 23, 2026 · Option Exercise47.7K @ $2.17
- Philippe Sauvage · June 23, 2026 · Sale47.7K @ $6.01
- Stacy Markel · June 23, 2026 · Option Exercise34.6K @ $1.74
- Stacy Markel · June 23, 2026 · Option Exercise90.4K @ $1.87
- Stacy Markel · June 23, 2026 · Sale125.0K @ $6.03
- Kerry Wentworth · June 23, 2026 · Option Exercise63.0K @ $2.93
- Kerry Wentworth · June 23, 2026 · Sale63.0K @ $6.02
- Robert Mashal · June 9, 2026 · Buy25.0K @ $4.73
- Robert Mashal · May 21, 2026 · Grant123.4K
- Cui Xiangmin · May 21, 2026 · Grant123.4K
- VERNON W ANTHONY · May 21, 2026 · Grant123.4K
Institutional Ownership
March 31, 2026
- Total shares held
- 217.14M
- Total value held
- $894.03M
- Institutional holders
- 224
- Unknown51.99M
- Unknown25.95M
- Unknown25.10M
- Unknown11.63M
- Unknown8.08M
- Unknown7.82M
- Unknown6.78M
- Unknown5.86M
- Unknown4.54M
- Unknown3.22M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Nuvation Bio Named In Penny Stock Watchlists
Nuvation Bio (NUVB) has been included in recent lists of penny stocks to watch for October 2026. The company's shares are currently trading near a key support level of $4.75, which has been tested multiple times. This technical position provides context for its inclusion in these speculative stock lists.
Nuvation Bio Named In Penny Stock Watchlists. Nuvation Bio (NUVB) has been included in recent lists of penny stocks to watch for October 2026. The company's shares are currently trading near a key support level of $4.75, which has been tested multiple times. This technical position provides context for its inclusion in these speculative stock lists.